C

Compugen Ltd
D

CGEN

2.01000
USD
0.04
(1.77%)
قبل الجلسة·2.01000USD0.00000(0.00%)
حجم التداول
20,585
الربح لكل سهم
-0
العائد الربحي
-
P/E
5
حجم السوق
190,403,131
نظرة عامة
أصول ذات صلة
A
ARVN
D
Arvinas
6.81500
-0.02700(-0.39%)
6.80000-0.01500(-0.22%)
C
CRVS
D
Corvus Pharmaceuticals
9.37000
-0.03500(-0.37%)
9.54000+0.17000(+1.81%)
MDGL
MDGL
D
Madrigal Pharmaceuticals
459.75
7.55(1.67%)
452.31-7.44(-1.62%)
T
TGTX
D
TG Therapeutics
54.360
-0.030(-0.06%)
53.820-0.540(-0.99%)
X
XNCR
D
Xencor
23.420
-0.140(-0.59%)
23.700+0.280(+1.20%)
المزيد

العنوان: Compugen Ltd

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.